Clinical Trial Update: Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing immunoadsorption versus plasma exchange for acute attacks in refractory neuromyelitis optica spectrum disorder (NMOSD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Neuromyelitis Optica Spectrum Disorder | Phase 2 | Status: UNKNOWN